Health Technology Assessment (Sep 2016)

A cluster randomised trial of strategies to increase cervical screening uptake at first invitation (STRATEGIC)

  • Henry C Kitchener,
  • Matthew Gittins,
  • Oliver Rivero-Arias,
  • Apostolos Tsiachristas,
  • Margaret Cruickshank,
  • Alastair Gray,
  • Loretta Brabin,
  • David Torgerson,
  • Emma J Crosbie,
  • Alexandra Sargent,
  • Chris Roberts

DOI
https://doi.org/10.3310/hta20680
Journal volume & issue
Vol. 20, no. 68

Abstract

Read online

Background: Falling participation by young women in cervical screening has been observed at a time that has seen an increase in the incidence of cervical cancer in the UK in women aged 90%. Conclusion: Women receiving their initial screening invitation frequently delay taking up the offer and the net impact of interventions was small. Timed appointments and SSKs sent to non-attenders at 6 months are likely to be a cost-effective means of increasing uptake and should be considered further. HPV vaccination in the catch-up programme was associated with an increased uptake of cervical screening. Future work should focus on optimising self-sampling in terms of age range, timing of offer for non-attenders and use of urine testing instead of vaginal samples. Trial registration: Current Controlled Trials ISRCTN52303479. Funding: This project was funded by the NIHR Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 20, No. 68. See the NIHR Journals Library website for further project information.

Keywords